Want to see GB:RKT full AI Analyst Report?
RKT Stock Chart & Stats
4950.00 p
110.00 p(2.22%)
At close: 4:00 PM EDT
4950.00 p
110.00 p(2.22%)
Day’s Range― - ―
52-Week Range4,421.00 p - 6,522.92 p
Previous CloseN/A
Volume978.30K
Average Volume (3M)1.55M
Market Cap
£32.64B
Enterprise Value41.15K
Total Cash (Recent Filing)£878.00M
Total Debt (Recent Filing)£10.16B
Price to Earnings (P/E)11.5
Beta0.90
Next Earnings
Mar 03, 2027EPS Estimate
1.91Next Dividend Ex-DateN/A
Dividend Yield6.48%
Share Statistics
EPS (TTM)4.46
Shares Outstanding634,861,100
10 Day Avg. Volume1,239,780
30 Day Avg. Volume1,554,548
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)5.26
Price to Sales (P/S)2.87
P/FCF Ratio23.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£6,221.71Price Target Upside25.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)3.36
Revenue Forecast (FY)£13.00B
Bulls Say, Bears Say
Bulls Say
Emerging-market GrowthSustained emerging-market growth, particularly in China and India, expands Reckitt’s addressable consumer base and supports durable volume and brand adoption. Repeated double-digit performance suggests stronger regional market positions rather than a single-quarter uplift.
Brand-led InnovationSuccessful launches across hygiene, sexual health and OTC categories demonstrate Reckitt’s ability to refresh established brands and capture premium demand. A broad innovation pipeline can sustain relevance, improve mix and defend market share across repeat-purchase categories.
Profitability And LeverageThe combination of materially higher profitability and sharply lower leverage strengthens financial resilience. Lower debt dependence improves flexibility to fund brand investment, absorb cost volatility and return capital, although the durability of the step-change still requires monitoring.
Bears Say
Infant-formula Litigation RiskThe Mead Johnson Enfamil litigation creates a potentially material, multi-year liability and reputational risk in infant nutrition. The ongoing bellwether trial and large consolidated caseload could pressure cash generation, management attention and the economics of the category.
Household Care WeaknessWeakness in Household Care exposes execution and competitive challenges in an important portfolio area. Persistent promotional intensity can erode volume, pricing and brand profitability, while Russia-related disruption adds uncertainty to the category’s recovery path.
Cost And Cash-conversion PressureInput-cost inflation and commodity volatility are compressing gross margins, while weak cash conversion shows earnings are not translating fully into cash. If these pressures persist, they could constrain reinvestment and reduce the flexibility of capital returns.
Reckitt News
RKT FAQ
What was Reckitt’s price range in the past 12 months?
Reckitt lowest share price was 4421.00 p and its highest was 6522.92 p in the past 12 months.
What is Reckitt’s market cap?
Reckitt’s market cap is £32.64B.
When is Reckitt’s upcoming earnings report date?
Reckitt’s upcoming earnings report date is Mar 03, 2027 which is in 191 days.
How were Reckitt’s earnings last quarter?
Reckitt released its earnings results on Jul 29, 2026. The company reported 1.011 p earnings per share for the quarter, missing the consensus estimate of 1.421 p by -0.41 p.
Is Reckitt overvalued?
According to Wall Street analysts Reckitt’s price is currently Undervalued.
Does Reckitt pay dividends?
Reckitt pays a Semiannually dividend of 88.6 p which represents an annual dividend yield of 6.48%. See more information on Reckitt dividends here
What is Reckitt’s EPS estimate?
Reckitt’s EPS estimate is 1.91.
How many shares outstanding does Reckitt have?
Reckitt has 634,861,100 shares outstanding.
What happened to Reckitt’s price movement after its last earnings report?
Reckitt reported an EPS of 1.011 p in its last earnings report, missing expectations of 1.421 p. Following the earnings report the stock price went up 4.328%.
Which hedge fund is a major shareholder of Reckitt?
Currently, no hedge funds are holding shares in GB:RKT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Reckitt Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
£6,221.71 (25.69% Upside)
£6,221.71 (25.69% Upside)
Blogger Sentiment
Bullish
GB:RKT Sentiment 100%
Sector Average 56%
Sector Average 56%
Insider Transactions
Bought Shares
Worth £249.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.01%
12-Months-Change
Fundamentals
Return on Equity
6.48%
Trailing 12-Months
Asset Growth
-0.78%
Trailing 12-Months
Company Description
Reckitt
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.
RKT Stock 12 Month Forecast
Average Price Target
6,221.71 p
▲(25.69% Upside)
Technical Analysis
Associated British Foods
―
British American Tobacco
―
Coca Cola HBC
―
Imperial Brands
―
Unilever
―